Outlook Therapeutics, Inc. (OTLK)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $71.17M
- P/E ratio
- —
- EPS
- —
- Volume
- 6,923,290
- 52-week high
- —
- 52-week low
- —
- Open
- $1.42
- Day high
- $1.52
- Day low
- $1.37
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $1.41M | -$62.42M | -$1.79 |
| 2024 | — | -$75.37M | -$4.06 |
| 2023 | — | -$58.98M | -$4.72 |
| 2022 | — | -$66.05M | -$0.31 |
| 2021 | — | -$53.16M | -$0.35 |
About Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical development, focused on inventing and bringing to market monoclonal antibody treatments for various eye conditions. Its flagship drug candidate, ONS-5010, is an ophthalmic formulation of bevacizumab currently undergoing crucial Phase III clinical trials. This investigational product is being evaluated for its potential to treat wet age-related macular degeneration and other serious retinal diseases. The company has forged strategic collaboration and licensing agreements with several partners, including IPCA Laboratories Limited, Laboratorios Liomont, S.A. de C.V., BioLexis Pte. Ltd., and Zhejiang Huahai Pharmaceutical Co., Ltd. Incorporated in 2010, the firm was formerly known as Oncobiologics, Inc., changing its name to Outlook Therapeutics, Inc. in November 2018. Its corporate base is located in Iselin, New Jersey.
- CEO
- Robert Charles Jahr
- Employees
- 17
- Country
- US
- IPO date
- Jun 14, 2016
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Outlook Therapeutics, Inc.'s stock price today?
- OTLK is trading at $1.38 as of Jul 20, 2026.
- What is Outlook Therapeutics, Inc.'s market cap?
- Outlook Therapeutics, Inc. (OTLK) has a market capitalization of $71.17M.
- Does Outlook Therapeutics, Inc. pay a dividend?
- Outlook Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Outlook Therapeutics, Inc. in?
- Outlook Therapeutics, Inc. operates in the Healthcare sector.